RNA Exosome Component EXOSC4 Amplified in Multiple Cancer Types Is Required for the Cancer Cell Survival

Kenzui Taniue1,2, Tanzina Tanu1, Yuki Shimoura1

  • 1Isotope Science Center, The University of Tokyo, Tokyo 113-0032, Japan.

Insights

The RNA exosome component EXOSC4 is amplified in many cancers and essential for pancreatic cancer cell survival. Its knockdown affects BIK and SESN2 gene expression, impacting tumor cell viability.

Area of Science:

  • Molecular Biology
  • Cancer Genomics
  • Cellular RNA Metabolism

Background:

  • The RNA exosome is a crucial conserved complex for RNA processing and degradation, vital for cellular function.
  • Dysregulation of RNA exosome components can contribute to cancer development and progression.

Purpose of the Study:

  • To investigate the role of RNA exosome components in cancer using integrated genomic and clinicopathological data.
  • To determine the functional significance of EXOSC4 in pancreatic cancer survival and gene regulation.

Main Methods:

  • Analysis of The Cancer Genome Atlas (TCGA) PanCancer Atlas data for 27 RNA exosome components across 32 tumor types.
  • Genomic and clinicopathological correlation analyses.
  • Experimental validation including gene knockdown and mRNA stability assays in pancreatic cancer cells.

Main Results:

  • The EXOSC4 gene, encoding an RNA exosome component, is amplified in multiple cancer types.
  • EXOSC4 alterations correlate with poor prognosis in pancreatic cancer patients.
  • EXOSC4 is essential for pancreatic cancer cell survival, repressing BIK expression and promoting SESN2 mRNA degradation.

Conclusions:

  • EXOSC4 plays a significant role in pancreatic cancer progression and cell survival.
  • EXOSC4-mediated regulation of BIK and SESN2 contributes to pancreatic tumor cell viability.
  • Targeting EXOSC4 may represent a potential therapeutic strategy for pancreatic cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
3.7K